1041 related articles for article (PubMed ID: 27826057)
1. Adenylyl cyclase 5 links changes in calcium homeostasis to cAMP-dependent cyst growth in polycystic liver disease.
Spirli C; Mariotti V; Villani A; Fabris L; Fiorotto R; Strazzabosco M
J Hepatol; 2017 Mar; 66(3):571-580. PubMed ID: 27826057
[TBL] [Abstract][Full Text] [Related]
2. Altered store operated calcium entry increases cyclic 3',5'-adenosine monophosphate production and extracellular signal-regulated kinases 1 and 2 phosphorylation in polycystin-2-defective cholangiocytes.
Spirli C; Locatelli L; Fiorotto R; Morell CM; Fabris L; Pozzan T; Strazzabosco M
Hepatology; 2012 Mar; 55(3):856-68. PubMed ID: 21987453
[TBL] [Abstract][Full Text] [Related]
3. Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.
Wang Q; Cobo-Stark P; Patel V; Somlo S; Han PL; Igarashi P
Kidney Int; 2018 Feb; 93(2):403-415. PubMed ID: 29042084
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase 6 inhibition reduces cysts by decreasing cAMP and Ca
Yanda MK; Liu Q; Cebotaru V; Guggino WB; Cebotaru L
J Biol Chem; 2017 Oct; 292(43):17897-17908. PubMed ID: 28887310
[TBL] [Abstract][Full Text] [Related]
5. ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.
Spirli C; Okolicsanyi S; Fiorotto R; Fabris L; Cadamuro M; Lecchi S; Tian X; Somlo S; Strazzabosco M
Gastroenterology; 2010 Jan; 138(1):360-371.e7. PubMed ID: 19766642
[TBL] [Abstract][Full Text] [Related]
6. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
Amura CR; Brodsky KS; Groff R; Gattone VH; Voelkel NF; Doctor RB
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
[TBL] [Abstract][Full Text] [Related]
7. Role of calcium in adult onset polycystic kidney disease.
Yanda MK; Liu Q; Cebotaru V; Guggino WB; Cebotaru L
Cell Signal; 2019 Jan; 53():140-150. PubMed ID: 30296477
[TBL] [Abstract][Full Text] [Related]
8. Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib.
Spirli C; Morell CM; Locatelli L; Okolicsanyi S; Ferrero C; Kim AK; Fabris L; Fiorotto R; Strazzabosco M
Hepatology; 2012 Dec; 56(6):2363-74. PubMed ID: 22653837
[TBL] [Abstract][Full Text] [Related]
9. A potential strategy for reducing cysts in autosomal dominant polycystic kidney disease with a CFTR corrector.
Yanda MK; Liu Q; Cebotaru L
J Biol Chem; 2018 Jul; 293(29):11513-11526. PubMed ID: 29875161
[TBL] [Abstract][Full Text] [Related]
10. Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice.
Spirli C; Okolicsanyi S; Fiorotto R; Fabris L; Cadamuro M; Lecchi S; Tian X; Somlo S; Strazzabosco M
Hepatology; 2010 May; 51(5):1778-88. PubMed ID: 20131403
[TBL] [Abstract][Full Text] [Related]
11. Conditional mutation of Pkd2 causes cystogenesis and upregulates beta-catenin.
Kim I; Ding T; Fu Y; Li C; Cui L; Li A; Lian P; Liang D; Wang DW; Guo C; Ma J; Zhao P; Coffey RJ; Zhan Q; Wu G
J Am Soc Nephrol; 2009 Dec; 20(12):2556-69. PubMed ID: 19939939
[TBL] [Abstract][Full Text] [Related]
12. Adenylyl cyclase 6 deficiency ameliorates polycystic kidney disease.
Rees S; Kittikulsuth W; Roos K; Strait KA; Van Hoek A; Kohan DE
J Am Soc Nephrol; 2014 Feb; 25(2):232-7. PubMed ID: 24158982
[TBL] [Abstract][Full Text] [Related]
13. Polycystin 2 regulates mitochondrial Ca
Kuo IY; Brill AL; Lemos FO; Jiang JY; Falcone JL; Kimmerling EP; Cai Y; Dong K; Kaplan DL; Wallace DP; Hofer AM; Ehrlich BE
Sci Signal; 2019 May; 12(580):. PubMed ID: 31064883
[TBL] [Abstract][Full Text] [Related]
14. Genetic reduction of cilium length by targeting intraflagellar transport 88 protein impedes kidney and liver cyst formation in mouse models of autosomal polycystic kidney disease.
Shao L; El-Jouni W; Kong F; Ramesh J; Kumar RS; Shen X; Ren J; Devendra S; Dorschel A; Wu M; Barrera I; Tabari A; Hu K; Haque N; Yambayev I; Li S; Kumar A; Behera TR; McDonough G; Furuichi M; Xifaras M; Lu T; Alhayaza RM; Miyabayashi K; Fan Q; Ajay AK; Zhou J
Kidney Int; 2020 Nov; 98(5):1225-1241. PubMed ID: 32610050
[TBL] [Abstract][Full Text] [Related]
15. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
[TBL] [Abstract][Full Text] [Related]
16. Role of follicle-stimulating hormone on biliary cyst growth in autosomal dominant polycystic kidney disease.
Onori P; Mancinelli R; Franchitto A; Carpino G; Renzi A; Brozzetti S; Venter J; Francis H; Glaser S; Jefferson DM; Alpini G; Gaudio E
Liver Int; 2013 Jul; 33(6):914-25. PubMed ID: 23617956
[TBL] [Abstract][Full Text] [Related]
17. Molecular and cellular pathogenesis of autosomal dominant polycystic kidney disease.
Bastos AP; Onuchic LF
Braz J Med Biol Res; 2011 Jul; 44(7):606-17. PubMed ID: 21625823
[TBL] [Abstract][Full Text] [Related]
18. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
[TBL] [Abstract][Full Text] [Related]
19. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.
Gainullin VG; Hopp K; Ward CJ; Hommerding CJ; Harris PC
J Clin Invest; 2015 Feb; 125(2):607-20. PubMed ID: 25574838
[TBL] [Abstract][Full Text] [Related]
20. Cyst formation following disruption of intracellular calcium signaling.
Kuo IY; DesRochers TM; Kimmerling EP; Nguyen L; Ehrlich BE; Kaplan DL
Proc Natl Acad Sci U S A; 2014 Sep; 111(39):14283-8. PubMed ID: 25228769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
